Theresa A. Guise, M.D., is Professor of Medicine and Jerry W. and Peg S. Throgmartin Professor of Oncology in the Department of Medicine, Division of Endocrinology at Indiana University. She completed medical school and internal medicine residency at the University of Pittsburgh School of Medicine and fellowship in endocrinology and metabolism at the University of Texas. She served on the faculty of the University of Texas until 2002, where she also held the Zachry Chair for Translational Research at the Institute for Drug Development of the Cancer Therapy and Research Center. She joined the University of Virginia in 2002 as the Gerald Aurbach Professor in the Division of Endocrinology and Mellon Investigator, where she directed a research in skeletal complications of malignancy and the Metabolic Bone Disease Clinic until July 2009 at which time she moved to Indiana University. Currently the Jerry and Peggy Throgmartin Professor of Oncology, Medicine and Pharmacology at the Indiana School of Medicine, Dr. Guise directs translational and clinical research on the musculoskeletal effects of cancer and cancer treatment.
She received the Fuller Albright Award in 1999 and the Paula Stern Achievement Award in 2012 from the American Society for Bone and Mineral Research (ASBMR). She was elected to the American Society for Clinical Investigation (ASCI) in 2004 and the Association of American Physicians (AAP) in 2008. She was Secretary-Treasurer and Councilor of the ASCI (2006-2010) and permanent member of NIH study section for Skeletal Biology and Skeletal Regeneration (2004-2009; Chair 2008, 2009) as well as Councilor for ASBMR (2004-2007). She served as Vice President and President of the International Bone and Mineral Society (2011-2015), Scholar of the Susan Komen Scientific Advisory Council (2010-2015) and Chairman of the Board of the Paget Foundation and Bone and Cancer Foundation (2010-2015). Her research interests include the effect of cancer and cancer treatment on the musculoskeletal system. Her research has been continuously funded by the NIH since 1992 and has also included funding from the Department of Defense, Susan G. Komen Foundation, Prostate Cancer Foundation, V-Foundation, Mary K. Ash Foundation and the Indiana Economic Development Corporation.